40018-10-8

Basic information

• Product Name: 2-TRIFLUOROMETHYLBENZOYLACETONITRILE
• Synonyms: 2-TRIFLUOROMETHYLBENZOYLACETONITRILE;2-TRIFUOROMETHYLBENZOYLACETONITRILE;3-Oxo-3-(2-trifluoromethyl-phenyl)-propionitrile;b-Oxo-2-(trifluoromethyl)-benzenepropanenitrile
• CAS NO: 40018-10-8
• Molecular Formula: C₁₀H₆F₃NO
• Molecular Weight: 213.16
• Mol File: 40018-10-8.mol

Chemical Properties

• Boiling Point: 308.9°C at 760 mmHg
• Flash Point: 140.6°C
• Appearance: /
• Density: 1.296g/cm³
• Vapor Pressure: 0.000662mmHg at 25°C
• Refractive Index: 1.469
• CAS DataBase Reference: 2-TRIFLUOROMETHYLBENZOYLACETONITRILE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-TRIFLUOROMETHYLBENZOYLACETONITRILE(40018-10-8)
• EPA Substance Registry System: 2-TRIFLUOROMETHYLBENZOYLACETONITRILE(40018-10-8)

Safety Data

• Hazard Codes: T
• Hazardous Substances Data: 40018-10-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-Trifluoromethylbenzoylacetonitrile is used as a chemical intermediate for the synthesis of pharmaceutical compounds. Its unique structure allows it to be a key component in the development of new drugs, potentially leading to advancements in medicine.
Used in Organic Chemistry Research:
2-Trifluoromethylbenzoylacetonitrile is used as a research compound in organic chemistry, where its properties and reactivity are studied. This can lead to a better understanding of the behavior of organic fluorides and their potential applications in various chemical processes.
Used in Chemical Reactions:
2-Trifluoromethylbenzoylacetonitrile is used as a reactant in various chemical reactions, where its trifluoromethyl and benzoylacetonitrile groups can participate in a range of transformations. This can result in the formation of new compounds with different properties and potential applications.

InChI:InChI=1/C10H6F3NO/c11-10(12,13)8-4-2-1-3-7(8)9(15)5-6-14/h1-4H,5H2

Upstream product

• 40018-09-5 o-Trifluormethylbenzoacetodinitril 
• 54109-16-9 2-(trifluoromethyl)phenacyl bromide 
• 344-96-7 2-trifluoromethyl-benzoic acid methyl ester 
• 75-05-8 acetonitrile 
• 17408-14-9 1-(2-(trifluoromethyl)phenyl)ethan-1-one 
• 312-94-7 2-trifluoromethylbenzoyl chloride 
• 447-60-9 2-(trifluoromethyl)benzonitrile 

Downstream Products

• 40018-11-9 (2-Amino-thiophen-3-yl)-(2-trifluoromethyl-phenyl)-methanone 
• 677713-10-9 2-amino-5-methyl-3-[2-(trifluoromethyl)benzoyl]thiophene 
• 502133-02-0 3-(2-(trifluoromethyl)phenyl)-1H-pyrazol-5-amine 
• 1232234-22-8 3-oxo-3-(2-trifluoromethyl-phenyl)-propionamide 
• 1232234-23-9 2-bromo-3-oxo-3-(2-trifluoromethyl-phenyl)-propionamide 
• 1232234-21-7 2-amino-4-(2-trifluoromethyl-phenyl)-thiazole-5-carboxylic acid amide 
• 1232233-87-2 2-[6-(4-methyl-piperazin-1-ylmethyl)-benzoimidazol-1-yl]-4-(2-trifluoromethyl-phenyl)-thiazole-5-carboxylic acid amide 
• 40018-17-5 1-methyl-5-(2-trifluoromethyl-phenyl)-1,3-dihydro-thieno[2,3-e][1,4]diazepin-2-one 
• 40018-15-3 5-(2-trifluoromethyl-phenyl)-1,3-dihydro-thieno[2,3-e][1,4]diazepin-2-one 
• 36811-65-1 7-chloro-5-(2-fluoro-phenyl)-1-methyl-1,3-dihydro-thieno[2,3-e][1,4]diazepin-2-one 
• 36811-66-2 7-chloro-5-(2-fluoro-phenyl)-1,3-dihydro-thieno[2,3-e][1,4]diazepin-2-one 
• 36912-58-0 5-(2-fluoro-phenyl)-1-methyl-1,3-dihydro-thieno[2,3-e][1,4]diazepin-2-one 
• 36811-60-6 5-(2-fluoro-phenyl)-1,3-dihydro-thieno[2,3-e][1,4]diazepin-2-one 
• 75473-39-1 N-{[3-(2-Trifluoromethyl-benzoyl)-thiophen-2-ylcarbamoyl]-methyl}-isobutyramide 

Relevant articles and documents

Fungal-Selective Resorcylate Aminopyrazole Hsp90 Inhibitors: Optimization of Whole-Cell Anticryptococcal Activity and Insights into the Structural Origins of Cryptococcal Selectivity

The essential eukaryotic chaperone Hsp90 regulates the form and function of diverse client proteins, many of which govern thermotolerance, virulence, and drug resistance in fungal species. However, use of Hsp90 inhibitors as antifungal therapeutics has be

COMPOUNDS AND METHODS FOR TREATING CANCER

Compounds useful as modulators of AhR, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds to treat, prevent or ameliorate AhR-mediated disorders such as cancers and inflammatory diseases are provided.

Thiazolyl-Benzimidazoles

The invention is directed to compounds of formula (1) and pharmaceutically acceptable salts thereof, methods for the preparation thereof, and methods of use thereof.

5-SULFANYLMETHYL-PYRAZOLO [1,5-A] PYRIMIDIN-7-OL DERIVATIVES AS CXCR2 ANTAGONISTS

The present invention relates to compounds of formula (I) and the use of these compounds as pharmaceuticals, e.g. in preventing or treating a CXCR2 receptor mediated condition or disease.